Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine-Reference-Cited by-同舟云学术

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

Published:2021-10-12 Issue:10 Volume:4 Page:e2128652
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Vesikari Timo¹,Finn Adam²,van Damme Pierre³,Leroux-Roels Isabel⁴,Leroux-Roels Geert⁴,Segall Nathan⁵,Toma Azhar⁶,Vallieres Gerald⁷,Aronson Ronnie⁸,Reich Dennis⁹,Arora Samir¹⁰,Ruane Peter J.¹¹,Cone Clancy L.¹²,Manns Michael¹³,Cosgrove Catherine¹⁴,Faust Saul N.¹⁵¹⁶,Ramasamy Maheshi N.¹⁷,Machluf Nathalie¹⁸,Spaans Johanna N.¹⁸,Yassin-Rajkumar Bebi¹⁸,Anderson David¹⁸,Popovic Vlad¹⁸,Diaz-Mitoma Francisco¹⁸,Rankin Bruce¹⁹,Manning Mary B¹⁹,Griffin Carl¹⁹,Haggag Amina Z¹⁹,Kutner Mark E¹⁹,Turner Mark¹⁹,Rizzardi Barbara¹⁹,Hayes Williams¹⁹,Levin Michael¹⁹,Sah Hamilton¹⁹,Garg Naveen¹⁹,Forsten Aino¹⁹,Seppä Ilkka¹⁹,Rössi Maija¹⁹,Ahonen Anitta¹⁹,Henriksson Olli¹⁹,Ukkonen Benita¹⁹,Kokko Satu¹⁹,Laajalahti Outi¹⁹,Paavola Pauliina¹⁹,

Affiliation:

1. Nordic Research Network Ltd, Tampere, Finland

2. Bristol Royal Hospital for Children, Bristol, United Kingdom

3. University of Antwerp–Center for the Evaluation of Vaccination, Universiteitsplein, Wilrijk, Belgium

4. Gent University, Gent, Belgium

5. Clinical Research Atlanta, Stockbridge, Georgia

6. Manna Research, Toronto, Ontario, Canada

7. Manna Research, Quebec, Quebec, Canada

8. LMC Diabetes and Endocrinology, Toronto, Ontario, Canada

9. Medicor Research Inc, Sudbury, Ontario, Canada

10. Aventiv Research, Columbus, Ohio

11. Ruane Clinical Research Group Inc, Los Angeles, California

12. Montana Medical Research Inc, Missoula

13. Medizinishe Hochschule, Hannover, Lower Saxony, Germany

14. St George’s University Hospital NHS Foundation Trust, London, United Kingdom

15. NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

16. Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom

17. Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital and University of Oxford, Oxford, United Kingdom

18. VBI Vaccines Inc, Cambridge, Massachusetts

19. for the CONSTANT Study Group

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784813/vesikari_2021_oi_210836_1633035200.50009.pdf

Reference29 articles.

1. Hepatitis A, B, and A/B vaccination series completion among US adults: a claims-based analysis.;Ghaswalla;Hum Vaccin Immunother,2018

2. Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.;Hechter;Vaccine,2019

3. Association of number of doses with hepatitis B vaccine series completion in US adults.;Bruxvoort;JAMA Netw Open,2020

4. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.;Mast;MMWR Recomm Rep,2005

5. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.;Coates;Clin Ther,2001

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination;Heliyon;2024-09

2. Updated vaccination and screening recommendations for hepatitis B: Implications for pharmacists;Journal of the American Pharmacists Association;2024-09

3. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review;Pharmaceuticals;2024-06-19

4. The immunogenicity of hepatitis B vaccine in psoriasis patients and by treatment type: A retrospective cohort study;Journal of the European Academy of Dermatology and Venereology;2024-06-10

5. A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice;iScience;2024-05